0001127602-18-021621.txt : 20180620
0001127602-18-021621.hdr.sgml : 20180620
20180620165453
ACCESSION NUMBER: 0001127602-18-021621
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180619
FILED AS OF DATE: 20180620
DATE AS OF CHANGE: 20180620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Ratcliffe Liam
CENTRAL INDEX KEY: 0001547100
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37568
FILM NUMBER: 18910010
MAIL ADDRESS:
STREET 1: C/O NEW LEAF VENTURE PARTNERS
STREET 2: 7 TIMES SQUARE - SUITE 3502
CITY: NEW YORK
STATE: NY
ZIP: 10036
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Edge Therapeutics, Inc.
CENTRAL INDEX KEY: 0001472091
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264231384
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
BUSINESS PHONE: 800-208-3343
MAIL ADDRESS:
STREET 1: 300 CONNELL DRIVE
STREET 2: SUITE 4000
CITY: BERKELEY HEIGHTS
STATE: NJ
ZIP: 07922
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2018-06-19
0001472091
Edge Therapeutics, Inc.
EDGE
0001547100
Ratcliffe Liam
C/O NEW LEAF VENTURES
TIMES SQ. TWR., 7 TIMES SQUARE, STE 3502
NEW YORK
NY
10036
1
Stock Option (Right To Purchase)
1.10
2018-06-19
4
A
0
20000
0
A
Common Stock
20000
20000
D
These options shall become exercisable upon the achievement of certain performance or time based criteria.
These options expire on the third anniversary of the vesting date.
/s/ Albert N. Marchio II, attorney-in-fact
2018-06-20